Dignitana to sponsor Susan G. Komen[® ]events in Dallas, New York and Los Angeles
Dignitana AB, world leader in scalp cooling innovation, announced today that its U.S. subsidiary, Dignitana, Inc., has signed on to sponsor three signature events in 2020 with Susan G. Komen®. The sponsorship extends Dignitana’s reach to hundreds of thousands of participants in the Susan G. Komen Race for the Cure® and MORE THAN PINK Walk® events in key Dignitana markets throughout year.
Dignitana is a proud supporter of Susan G. Komen and their mission to save lives by meeting the most critical needs in communities and investing in breakthrough research to prevent and cure breast cancer.
“As the world’s leading nonprofit breast cancer organization, Susan G. Komen launched a movement that has made a worldwide impact in the fight against breast cancer,” says William Cronin, CEO of Dignitana. “We are honored to support Susan G. Komen and the important work they do from the community level up.”
The Susan G. Komen Race for the Cure® Series is the world’s largest and most successful education and fundraising event for breast cancer ever created. It celebrates breast cancer survivorship and honors those who have lost their battle with the disease. Komen’s MORE THAN PINK Walk® brings together an empowered community of hope to raise funds for breast cancer treatment, patient advocacy and lifesaving research.
“Susan G. Komen remains committed to the fight against breast cancer, taking every step we can toward our mission of saving lives and supporting those affected by breast cancer,” says Carrie Stovall, Vice President, Fundraising and Events at Susan G. Komen. “We are so grateful for supporters like Dignitana and look forward to seeing the impact our partnership will make.”
The alliance kicks off this month with the Susan G. Komen MORE THAN PINK Walk® Los Angeles County on February 29 at Dodger Stadium in Los Angeles, California and will be followed by the prestigious Susan G. Komen Race for the Cure® Greater New York City on September 13. For Breast Cancer Awareness Month in October, the sponsorship will be in Dignitana, Inc.’s “backyard,” with the Susan G. Komen MORE THAN PINK Walk® Dallas County held on October 24 at the North Park Center in Dallas, Texas.
Since its founding, Komen has funded more than $1 billion in research and invested more than $2.3 billion to provide screening, diagnostics, education, treatment and psychosocial support to people in communities across the U.S. and in 60 countries worldwide.
Sign Up Here to join Team DigniCap and walk with Dignitana at the Susan G. Komen MORE THAN PINK Walk® on February 29 in Los Angeles.
For More Information Contact
Investor Relations +1 469 518 5031 investorrelations@dignitana.com
About Dignitana Inc.
Dignitana, Inc. is a subsidiary of Dignitana AB, the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Learn more at www.dignitana.se and www.dignicap.com. Erik Penser Bank AB, Certified Adviser, +46 (0) 8 463 83 00 certifiedadviser@penser.se www.penser.se
About Susan G. Komen®
Susan G. Komen® is the world’s leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow’s cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at ww5.komen.org/social.
For More Information Contact
Investor Relations +1 469 518 5031 investorrelations@dignitana.com
About Dignitana
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Learn more at www.dignitana.se and www.dignicap.com.
Eric Penser Bank AB, Certified Adviser, Box 7405,103 91 Stockholm Phone: +46 8-463 83 00 certifiedadviser@penser.se www.penser.se
Tags:
